In vitro stability of poly(D,L-lactide) and poly(D,L-lactide)/poloxamer nanoparticles in gastrointestinal fluids

Drug Development and Industrial Pharmacy

Volumn 23, Issue 12, 1997, Pages 1191-1200

  Reich, Gabriele ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NANOPARTICLE; POLOXAMER; POLYLACTIDE;

ARTICLE; CONFORMATIONAL TRANSITION; GASTROINTESTINAL SECRETION; GEL PERMEATION CHROMATOGRAPHY; INTESTINE FLUID; MOLECULAR STABILITY; PARTICLE SIZE; STOMACH JUICE; ZETA POTENTIAL;

EID: 0031445317     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.3109/03639049709146156     Document Type: Article

References (23)

1. P. Couvreur, C. Dubernet, and F. Puisieux, Adv. Drug. Del. Rev., 10, 141 (1993).
2. J. Kreuter, Adv. Drug Del. Rev., 7, 71 (1991).
3. P. U. Jani, J. Pharm. Pharmacol., 41, 809 (1989).
4. D. T. O'Hagan, Adv. Drug Del. Rev., 5, 265 (1990).
5. A. T. Florence, A. M. Hillery, N. Hussain, and P. U. Jain, J. Contr. Rel., 36, 39 (1995).
6. P. U. Jani, G. W. Halbert, J. Landridge, and A. T. Florence, J. Pharm. Pharmacol., 42, 821 (1990).
7. M. A. Jepson, N. L. Simmons, D. T. O'Hagan, and B. H. Hirst, J. Drug Targeting, 1, 245 (1993).
8. A. M. Hillery and A. T. Florence, Int. J. Pharm., 132, 123 (1996).
9. B. Naisbett, B. Wagenaar, J. Bouwstra, and H. F. Junginger, Proceed. Intern. Symp. Control. Rel. Bioact. Mater., 20, 216 (1993).
10. J. H. Eldrige, C. J. Hammond, J. A. Meulbroek, J. K. Staas, R. M. Gilley, and T. R. Tice, J. Contr. Rel., 11, 205 (1990).
11. J. H. Eldridge, J. K. Staas, J. A. Meulbroek, J. R. McGee, T. R. Tice, and R. M. Gilley, Mol. Immunol., 28, 287 (1991).
12. J. K. Staas, J. H. Eldridge, J. D. Morgan, O. B. Finck, T. R. Tice, and R. M. Gilley, Proceed. Intern. Symp. Control. Rel. Bioact. Mater., 18, 619 (1991).
13. E. Pilar Calvo., J. Vila-Jato, and M. J. Alonso, Proceed. Intern. Symp. Control. Rel. Bioact. Mater., 18, 278 (1991).
14. M. D. Coffin and J. W. McGinity, Pharm. Res., 9, 200 (1992).
15. T. Niwa, H. Takeuchi, T. Hino, N. Kunou, and Y. Kawashima, J. Pharm. Sci., 83, 727 (1994).
16. S. S. Guterres, H. Fessi, G. Barratt, J.-P. Devissaguet, and F. Puisieux, Int. J. Pharm., 113, 57 (1995).
17. A. Belballa, C. Vauthier, H. Fessi, J.-P. Devissaguet, and F. Puisieux, Int. J. Pharm., 129, 95 (1996).
18. V. Massen, F. Maurin, J.-P. Devissaguet, and H. Fessi, Int. J. Pharm., 139, 113 (1996).
19. F. B. Landry, B. V. Bazile, G. Spenlehauer, M. Vellard, and J. Kreuter, Biomaterials, 17, 715 (1996).
20. H. von Büren, Dissertation, Heidelberg, 1989.
21. H. Fessi, J.-P. Devissaguet, F. Puisieux, and C. Thies, European patent 0275796 B1 (1987).
22. S. E. Frisbee and J. W. McGinity, Eur. J. Pharm. Bioparm., 40, 355 (1994).
23. G. Reich, Use of DSC to study the degradation behavior of PLA and PLGA microparticles. Drug Dev. Ind. Pharm., accepted.